(Reuters) – Most cancers diagnostics enterprise Precise Sciences Corp (O:) is in superior negotiations to acquire health care business Genomic Overall health Inc (O:) for about $2.8 billion to bolster its most cancers testing, Bloomberg reported on Saturday.
A offer could be declared as early as upcoming week but the talks could still be delayed or slide apart entirely, according to the report, which cited individuals common with the make any difference.
Correct Sciences and Genomic Health and fitness did not answer instantly to a Reuters ask for for remark on Saturday.
Fusion Media or everyone concerned with Fusion Media will not acknowledge any legal responsibility for reduction or harm as a outcome of reliance on the details which includes data, offers, charts and buy/market alerts contained inside this web page. You should be fully educated concerning the challenges and fees connected with investing the fiscal markets, it is a person of the riskiest financial commitment sorts feasible.
Supply website link No tags for this post.